IMCC - IM Cannabis Corp.
2.12
-0.080 -3.774%
Share volume: 4,003
Last Updated: Tue 04 Feb 2025 10:00:00 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.24%
PREVIOUS CLOSE
CHG
CHG%
$2.20
0.02
0.01%
Fundamental analysis
4%
Profitability
0%
Dept financing
0%
Liquidity
0%
Performance
10%
Performance
5 Days
-2.30%
1 Month
-21.77%
3 Months
3.92%
6 Months
-21.77%
1 Year
776.03%
2 Year
59.40%
Key data
Stock price
$2.12
DAY RANGE
$2.10 - $2.21
52 WEEK RANGE
$0.24 - $4.49
52 WEEK CHANGE
$754.84
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Oren Shuster
Region: US
Website: imcannabis.com
Employees: 340
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: imcannabis.com
Employees: 340
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
IM Cannabis Corp. engages in breeding, growing, and supply medical cannabis products. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers.
Recent news